Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Growth Factors as Immunotherapeutic Targets in Cardiovascular Disease.

Mindur JE, Swirski FK.

Arterioscler Thromb Vasc Biol. 2019 Jul;39(7):1275-1287. doi: 10.1161/ATVBAHA.119.311994. Epub 2019 May 16.

PMID:
31092009
2.

Sleep modulates haematopoiesis and protects against atherosclerosis.

McAlpine CS, Kiss MG, Rattik S, He S, Vassalli A, Valet C, Anzai A, Chan CT, Mindur JE, Kahles F, Poller WC, Frodermann V, Fenn AM, Gregory AF, Halle L, Iwamoto Y, Hoyer FF, Binder CJ, Libby P, Tafti M, Scammell TE, Nahrendorf M, Swirski FK.

Nature. 2019 Feb;566(7744):383-387. doi: 10.1038/s41586-019-0948-2. Epub 2019 Feb 13.

PMID:
30760925
3.

Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease.

He S, Kahles F, Rattik S, Nairz M, McAlpine CS, Anzai A, Selgrade D, Fenn AM, Chan CT, Mindur JE, Valet C, Poller WC, Halle L, Rotllan N, Iwamoto Y, Wojtkiewicz GR, Weissleder R, Libby P, Fernández-Hernando C, Drucker DJ, Nahrendorf M, Swirski FK.

Nature. 2019 Feb;566(7742):115-119. doi: 10.1038/s41586-018-0849-9. Epub 2019 Jan 30.

PMID:
30700910
4.

Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis.

Anzai A, Mindur JE, Halle L, Sano S, Choi JL, He S, McAlpine CS, Chan CT, Kahles F, Valet C, Fenn AM, Nairz M, Rattik S, Iwamoto Y, Fairweather D, Walsh K, Libby P, Nahrendorf M, Swirski FK.

J Exp Med. 2019 Feb 4;216(2):369-383. doi: 10.1084/jem.20180722. Epub 2019 Jan 22.

PMID:
30670465
5.

Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood.

Yadav SK, Boppana S, Ito N, Mindur JE, Mathay MT, Patel A, Dhib-Jalbut S, Ito K.

Proc Natl Acad Sci U S A. 2017 Oct 31;114(44):E9318-E9327. doi: 10.1073/pnas.1615715114. Epub 2017 Oct 16.

6.

Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis.

Nairz M, Haschka D, Dichtl S, Sonnweber T, Schroll A, Aßhoff M, Mindur JE, Moser PL, Wolf D, Swirski FK, Theurl I, Cerami A, Brines M, Weiss G.

Sci Rep. 2017 Oct 12;7(1):13012. doi: 10.1038/s41598-017-13046-3.

7.

The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes.

Anzai A, Choi JL, He S, Fenn AM, Nairz M, Rattik S, McAlpine CS, Mindur JE, Chan CT, Iwamoto Y, Tricot B, Wojtkiewicz GR, Weissleder R, Libby P, Nahrendorf M, Stone JR, Becher B, Swirski FK.

J Exp Med. 2017 Nov 6;214(11):3293-3310. doi: 10.1084/jem.20170689. Epub 2017 Oct 4.

8.

IL-27: a potential biomarker for responders to glatiramer acetate therapy.

Mindur JE, Valenzuela RM, Yadav SK, Boppana S, Dhib-Jalbut S, Ito K.

J Neuroimmunol. 2017 Mar 15;304:21-28. doi: 10.1016/j.jneuroim.2016.07.004. Epub 2016 Jul 17.

PMID:
27449853
9.

Advances in the immunopathogenesis of multiple sclerosis.

Yadav SK, Mindur JE, Ito K, Dhib-Jalbut S.

Curr Opin Neurol. 2015 Jun;28(3):206-19. doi: 10.1097/WCO.0000000000000205. Review.

PMID:
25887768
10.

Early treatment with anti-VLA-4 mAb can prevent the infiltration and/or development of pathogenic CD11b+CD4+ T cells in the CNS during progressive EAE.

Mindur JE, Ito N, Dhib-Jalbut S, Ito K.

PLoS One. 2014 Jun 4;9(6):e99068. doi: 10.1371/journal.pone.0099068. eCollection 2014.

11.

Comparison of IFN-β inducible gene expression in primary-progressive and relapsing-remitting multiple sclerosis.

Boppana S, Mindur JE, Balashov KE, Dhib-Jalbut S, Ito K.

J Neuroimmunol. 2013 Dec 15;265(1-2):68-74. doi: 10.1016/j.jneuroim.2013.10.007. Epub 2013 Oct 24.

PMID:
24200257

Supplemental Content

Loading ...
Support Center